Philadelphia 76ers · — · #—
—
| Period | GP | MIN | PTS | REB | AST | PRA | STL | BLK | TOV | 2PM | 2PA | 2P% | 3PM | 3PA | 3P% | FTM | FTA | FT% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Last 3 | 3 | 5.6 | 3.0 | 1.3 | 0.3 | 4.7 | 0.0 | 0.0 | 0.0 | 0.7 | 0.7 |
| 100.0% |
| 0.3 |
| 0.3 |
| 100.0% |
| 0.7 |
| 1.3 |
| 50.0% |
| Last 5 | 5 | 5.4 | 2.4 | 1.2 | 0.2 | 3.8 | 0.0 | 0.0 | 0.2 | 0.4 | 0.4 | 100.0% | 0.4 | 0.4 | 100.0% | 0.4 | 0.8 | 50.0% |
| Last 10 | 10 | 8.9 | 4.2 | 1.9 | 0.7 | 6.8 | 0.2 | 0.1 | 0.4 | 1.2 | 1.7 | 70.6% | 0.4 | 0.9 | 44.4% | 0.6 | 0.9 | 66.7% |
| Last 20 | 20 | 11.0 | 5.5 | 2.8 | 0.7 | 9.0 | 0.3 | 0.1 | 0.5 | 1.2 | 1.9 | 63.2% | 0.8 | 1.6 | 46.9% | 0.9 | 1.2 | 75.0% |
| Season | 64 | 11.9 | 4.3 | 3.0 | 0.5 | 7.8 | 0.4 | 0.2 | 0.4 | 1.0 | 1.8 | 55.1% | 0.5 | 1.5 | 33.7% | 0.8 | 1.1 | 73.5% |
low usage, low on-ball creation, low assist rate, low post-ups
2025-26 season · fitted over 2022-23–2025-26
Style profile over 446 qualified players (8+ games, 10+ min/game). 100% is an identical profile; 50% is unrelated.
| Date | Matchup | W/L | MIN | PTS | REB | AST | STL | BLK | TOV | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | +/- |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-12 | PHI vs. MIL | W | 7.6 | 7 | 2 | 0 | 0 | 0 | 0 | 2 | 2 | 100.0% | 1 | 1 | 100.0% | 2 | 4 | 50.0% | -13.0 |
| 2026-04-09 | PHI @ HOU | L | 4.3 | 2 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -6.0 |
| 2026-04-04 | PHI vs. DET | L | 4.9 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -4.0 |
| 2026-04-01 | PHI @ WAS | W | 3.0 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0.0 |
| 2026-03-25 | PHI vs. CHI | W | 7.2 | 3 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 100.0% | 1 | 1 | 100.0% | 0 | 0 | 0.0% | -14.0 |
| 2026-03-23 | PHI vs. OKC | L | 10.3 | 4 | 4 | 1 | 0 | 0 | 0 | 2 | 5 | 40.0% | 0 | 2 | 0.0% | 0 | 1 | 0.0% | 1.0 |
| 2026-03-21 | PHI @ UTA | W | 17.9 | 8 | 5 | 3 | 1 | 1 | 1 | 3 | 5 | 60.0% | 0 | 1 | 0.0% | 2 | 2 | 100.0% | 5.0 |
| 2026-03-19 | PHI @ SAC | W | 6.0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3 | 0.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -9.0 |
| 2026-03-12 | PHI @ DET | L | 18.3 | 16 | 1 | 2 | 0 | 0 | 2 | 6 | 6 | 100.0% | 2 | 2 | 100.0% | 2 | 2 | 100.0% | -5.0 |
| 2026-03-10 | PHI vs. MEM | W | 9.3 | 2 | 2 | 0 | 1 | 0 | 0 | 1 | 3 | 33.3% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 5.0 |
| 2026-03-09 | PHI @ CLE | L | 12.2 | 5 | 2 | 0 | 1 | 0 | 1 | 2 | 3 | 66.7% | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 5.0 |
| 2026-03-07 | PHI @ ATL | L | 17.4 | 9 | 5 | 1 | 1 | 0 | 2 | 3 | 7 | 42.9% | 1 | 3 | 33.3% | 2 | 2 | 100.0% | 1.0 |
| 2026-03-04 | PHI vs. UTA | W | 28.1 | 22 | 10 | 2 | 0 | 1 | 1 | 7 | 12 | 58.3% | 4 | 7 | 57.1% | 4 | 6 | 66.7% | 5.0 |
| 2026-03-03 | PHI vs. SAS | L | 19.5 | 20 | 7 | 0 | 0 | 0 | 1 | 7 | 10 | 70.0% | 2 | 5 | 40.0% | 4 | 4 | 100.0% | -1.0 |
| 2026-02-26 | PHI vs. MIA | W | 3.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 1.0 |
| 2026-02-24 | PHI @ IND | W | 10.3 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 0.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -1.0 |
| 2026-02-22 | PHI @ MIN | W | 11.9 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 7.0 |
| 2026-02-21 | PHI @ NOP | L | 16.4 | 9 | 6 | 1 | 1 | 0 | 0 | 3 | 5 | 60.0% | 2 | 3 | 66.7% | 1 | 1 | 100.0% | 5.0 |
| 2026-02-19 | PHI vs. ATL | L | 10.3 | 4 | 3 | 2 | 1 | 0 | 0 | 1 | 3 | 33.3% | 1 | 2 | 50.0% | 1 | 2 | 50.0% | -3.0 |
| 2026-02-03 | PHI @ GSW | W | 2.1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -3.0 |
| 2026-02-02 | PHI @ LAC | W | 2.3 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 2.0 |
| 2026-01-31 | PHI vs. NOP | W | 8.1 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 2 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0.0 |
| 2026-01-27 | PHI vs. MIL | W | 2.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 3.0 |
| 2026-01-26 | PHI @ CHA | L | 20.1 | 9 | 2 | 0 | 3 | 0 | 0 | 3 | 8 | 37.5% | 3 | 6 | 50.0% | 0 | 0 | 0.0% | 8.0 |
| 2026-01-20 | PHI vs. PHX | L | 6.4 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -3.0 |
| 2026-01-19 | PHI vs. IND | W | 23.6 | 5 | 6 | 0 | 4 | 0 | 0 | 2 | 5 | 40.0% | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 13.0 |
| 2026-01-16 | PHI vs. CLE | L | 3.6 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 2 | 0.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -5.0 |
| 2026-01-14 | PHI vs. CLE | L | 14.9 | 2 | 4 | 3 | 2 | 1 | 0 | 1 | 5 | 20.0% | 0 | 4 | 0.0% | 0 | 0 | 0.0% | -10.0 |
| 2026-01-12 | PHI @ TOR | W | 13.8 | 6 | 1 | 0 | 0 | 0 | 1 | 2 | 3 | 66.7% | 1 | 2 | 50.0% | 1 | 2 | 50.0% | 13.0 |
| 2026-01-11 | PHI @ TOR | L | 16.8 | 7 | 6 | 0 | 0 | 0 | 1 | 3 | 8 | 37.5% | 0 | 4 | 0.0% | 1 | 2 | 50.0% | 9.0 |
| 2026-01-09 | PHI @ ORL | W | 9.4 | 2 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | 9.0 |
| 2026-01-07 | PHI vs. WAS | W | 4.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -5.0 |
| 2026-01-05 | PHI vs. DEN | L | 11.6 | 6 | 4 | 0 | 1 | 1 | 0 | 3 | 4 | 75.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 11.0 |
| 2026-01-03 | PHI @ NYK | W | 9.3 | 4 | 3 | 0 | 0 | 0 | 0 | 2 | 4 | 50.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -2.0 |
| 2026-01-01 | PHI @ DAL | W | 4.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | -4.0 |
| 2025-12-28 | PHI @ OKC | L | 3.5 | 2 | 3 | 0 | 0 | 0 | 0 | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0.0 |
| 2025-12-26 | PHI @ CHI | L | 10.1 | 1 | 3 | 0 | 0 | 1 | 1 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 1 | 2 | 50.0% | -6.0 |
| 2025-12-23 | PHI vs. BKN | L | 12.8 | 5 | 4 | 1 | 0 | 0 | 1 | 2 | 4 | 50.0% | 0 | 2 | 0.0% | 1 | 1 | 100.0% | -5.0 |
| 2025-12-20 | PHI vs. DAL | W | 17.7 | 2 | 8 | 0 | 1 | 0 | 0 | 1 | 5 | 20.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | 15.0 |
| 2025-12-19 | PHI @ NYK | W | 13.8 | 3 | 1 | 0 | 0 | 1 | 0 | 0 | 3 | 0.0% | 0 | 2 | 0.0% | 3 | 4 | 75.0% | -6.0 |
| 2025-12-14 | PHI @ ATL | L | 17.4 | 4 | 5 | 1 | 1 | 1 | 0 | 0 | 2 | 0.0% | 0 | 0 | 0.0% | 4 | 6 | 66.7% | 13.0 |
| 2025-12-12 | PHI vs. IND | W | 13.7 | 6 | 2 | 0 | 0 | 0 | 2 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 6 | 8 | 75.0% | -15.0 |
| 2025-12-07 | PHI vs. LAL | L | 17.2 | 4 | 4 | 0 | 0 | 0 | 0 | 1 | 4 | 25.0% | 1 | 3 | 33.3% | 1 | 2 | 50.0% | 7.0 |
| 2025-12-05 | PHI @ MIL | W | 18.3 | 18 | 2 | 1 | 1 | 0 | 0 | 5 | 10 | 50.0% | 4 | 8 | 50.0% | 4 | 4 | 100.0% | 7.0 |
| 2025-12-04 | PHI vs. GSW | W | 12.3 | 7 | 5 | 0 | 0 | 0 | 2 | 2 | 3 | 66.7% | 1 | 2 | 50.0% | 2 | 2 | 100.0% | -5.0 |
| 2025-12-02 | PHI vs. WAS | W | 24.3 | 10 | 12 | 1 | 0 | 1 | 1 | 4 | 9 | 44.4% | 2 | 5 | 40.0% | 0 | 2 | 0.0% | 8.0 |
| 2025-11-28 | PHI @ BKN | W | 12.0 | 4 | 2 | 1 | 0 | 1 | 0 | 2 | 3 | 66.7% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -3.0 |
| 2025-11-25 | PHI vs. ORL | L | 21.3 | 9 | 5 | 1 | 0 | 0 | 2 | 4 | 7 | 57.1% | 1 | 2 | 50.0% | 0 | 0 | 0.0% | -12.0 |
| 2025-11-23 | PHI vs. MIA | L | 4.0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -2.0 |
| 2025-11-20 | PHI @ MIL | W | 10.9 | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 2 | 0.0% | 0 | 1 | 0.0% | 2 | 2 | 100.0% | 0.0 |
| 2025-11-19 | PHI vs. TOR | L | 23.2 | 9 | 9 | 2 | 0 | 1 | 1 | 4 | 6 | 66.7% | 1 | 1 | 100.0% | 0 | 0 | 0.0% | -3.0 |
| 2025-11-17 | PHI vs. LAC | W | 3.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 1.0 |
| 2025-11-14 | PHI @ DET | L | 10.0 | 2 | 4 | 0 | 0 | 0 | 0 | 0 | 1 | 0.0% | 0 | 1 | 0.0% | 2 | 2 | 100.0% | -11.0 |
| 2025-11-11 | PHI vs. BOS | W | 10.3 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 2 | 0.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | 3.0 |
| 2025-11-09 | PHI vs. DET | L | 17.5 | 12 | 5 | 0 | 0 | 0 | 2 | 5 | 6 | 83.3% | 2 | 2 | 100.0% | 0 | 0 | 0.0% | -4.0 |
| 2025-11-08 | PHI vs. TOR | W | 5.4 | 0 | 2 | 1 | 0 | 0 | 0 | 0 | 1 | 0.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 6.0 |
| 2025-11-05 | PHI @ CLE | L | 8.3 | 0 | 3 | 0 | 1 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -17.0 |
| 2025-11-04 | PHI @ CHI | L | 18.7 | 2 | 3 | 1 | 0 | 0 | 0 | 1 | 3 | 33.3% | 0 | 0 | 0.0% | 0 | 1 | 0.0% | 8.0 |
| 2025-11-02 | PHI @ BKN | W | 18.1 | 2 | 4 | 0 | 0 | 0 | 1 | 1 | 4 | 25.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 7.0 |
| 2025-10-31 | PHI vs. BOS | L | 11.4 | 2 | 1 | 0 | 0 | 0 | 0 | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 3.0 |
| 2025-10-28 | PHI @ WAS | W | 5.9 | 8 | 2 | 0 | 1 | 0 | 0 | 3 | 3 | 100.0% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | 2.0 |
| 2025-10-27 | PHI vs. ORL | W | 14.3 | 4 | 5 | 0 | 0 | 1 | 0 | 2 | 8 | 25.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 6.0 |
| 2025-10-25 | PHI vs. CHA | W | 14.8 | 0 | 4 | 0 | 0 | 2 | 2 | 0 | 3 | 0.0% | 0 | 3 | 0.0% | 0 | 0 | 0.0% | -11.0 |
| 2025-10-22 | PHI @ BOS | W | 18.9 | 6 | 4 | 0 | 0 | 0 | 0 | 3 | 4 | 75.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 3.0 |